ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Essity Uses eConsent To Optimize Enrollment

  See how a global hygiene and health company was able to deploy virtual methods through a strategic partnership to recruit and retain participants, streamline consent, and analyze patient data.

• Why Data Integrity Still Matters — Even As Clinical Trials Evolve

  Data integrity remains essential for compliance and patient safety. Learn strategies to maintain accuracy and reliability as clinical research evolves toward more connected, technology-driven models.

• Immuno-Inflammation Clinical Trials: Challenges And Solutions

  Learn why having a strong and robust eCOA solution, along with an understanding of the specific challenges of this therapeutic area, is critical to the success of immuno-inflammation clinical trials.

• Leveraging eCOA To Improve Patient Adherence In Clinical Trials

  Patient adherence is one of the biggest challenges in clinical trials. eCOA solutions offer intuitive and engaging tools that encourage participants to complete their assessments on time.

• Improving Patient Outcomes With Wearables In Major Depressive Disorder

  Learn how medical-grade wearable devices can help advance treatments in conditions like major depressive disorder and paint a more complete picture of patients with this often debilitating condition.

• Hearing The Patient Voice Through Technology & eCOA

  Discover the benefits of gathering patient data through electronic clinical outcome assessments and electronic patient-reported outcomes over paper versions.

• Key CTMS Capabilities To Improve Financial Management

  In clinical research, utilizing your clinical trial management system (CTMS) to its fullest potential can allow for more streamlined financial management, visit management, compliance, patient recruitment, and more. This blog outlines what you should look for in a CTMS to maximize your organization’s return on investment (ROI).

• Save Time And Money By Using AI To Compare CRO Proposals

  Examine tried and true methods of finding outsource partners with the up-and-coming AI technologies that aim to make that process quicker, easier, and possibly cheaper.

• Experts Discuss AI's Future In Pharma

  At the J.P. Morgan Health Conference, experts explored the transformative potential of artificial intelligence (AI) in drug development and deliberated on the essential requirements for ensuring positive outcomes in this evolving field.

• To Counter Bias, Counterbalance

  It’s easy to overlook the effects a survey’s format can have on responses, but those effects are potent sources of bias. Modern EDC allows you to systematically vary both question and response option order. This practice, called counterbalancing, guards against unwanted order effects.